Skip to main content

Table 1 Baseline characteristics among older adult patients with metastatic BTC before and after propensity score matching

From: An age-group analysis on the efficacy of chemotherapy in older adult patients with metastatic biliary tract cancer: a Japanese cancer registry cohort study

 

Original Data Set

 

Matched Data Set

Variables

Chemotherapy (n = 116)

BSC

(n = 91)

Sdiff

*P value

 

Chemotherapy (n = 64)

BSC

(n = 64)

Sdiff

†P value

Age, mean (SD)

76.5 (4.93)

79.7 (5.49)

0.618

< 0.001

 

78.2 (5.01)

78.1 (4.70)

0.032

0.856

Sex, n (%)

         

 Male

63 (54.3)

50 (54.9)

0.013

> 0.99

 

36 (56.2)

35 (54.7)

0.031

> 0.99

 Female

53 (45.7)

41 (45.1)

   

28 (43.8)

29 (45.3)

  

Body mass index, n (%)

         

 <19

14 (12.1)

15 (16.5)

0.126

0.422

 

8 (12.5)

11 (17.2)

0.132

0.62

 ≥19

102 (87.9)

76 (83.5)

   

56 (87.5)

53 (82.8)

  

Tumor Location, n (%)

         

 Gallbladder

45 (38.8)

27 (29.7)

0.193

0.188

 

24 (37.5)

21 (32.8)

0.098

0.711

 Non-Gallbladder

71 (61.2)

64 (70.3)

   

40 (62.5)

43 (67.2)

  

Barthel Index, n(%)

         

 ≥95

105 (90.5)

60 (65.9)

0.624

< 0.001

 

53 (82.8)

53 (82.8)

< 0.001

> 0.99

 ≤94

11 (9.5)

31 (34.1)

   

11 (17.2)

11 (17.2)

  

CCI, n (%)

         

 0

68 (58.6)

55 (60.4)

0.037

0.887

 

38 (59.4)

33 (51.6)

0.158

0.477

 ≥1

48 (41.4)

36 (39.6)

   

26 (40.6)

31 (48.4)

  
  1. BSC, best supportive care; SD, standard deviations; CCI, Charlson Comorbidity Index; Sdiff, standardized difference.
  2. *P value for Student t-test or Chi-square test; †P value for Mantel-Haenszel test.